Stocks To Buy Today: IDFC First Bank, Bharti Hexacom, KFin Tech, MCX And More
Here are all the top 'buy' calls from analysts you need to know about on Thursday.

Analysts have 'buy' calls on shares of IDFC First Bank Ltd., Bharti Hexacom Ltd., KFin Technologies Ltd., Multi Commodity Exchange Of India Ltd., Gravita India Ltd. and Healthcare Global Enterprises Ltd.
The stock calls came from Ravi Singh, Senior Vice President - Retail Research, Religare Broking; Kushal Gandhi, Technical Analyst, StoxBox; and Amit Goel, founder of Amit Ventures.
IDFC First Bank
Singh recommends buying the stock with a target price of Rs 75 and a stop loss at Rs 60. Over the past 12 months, the stock has declined 24.90%. The relative strength index is at 46.18.
According to Bloomberg, 22 analysts track the stock: 10 rate it a 'buy,' and eight a 'hold' and four a 'sell'. The consensus 12-month target price is Rs 69.64, indicating a potential upside of 7.7%.
Bharti Hexacom
Gandhi has suggested buying this stock with a target price of Rs 1,741 and a stop loss of Rs 1,468. The stock has risen by 90.07% so far this year. Its relative strength index is at 66.95.
As per Bloomberg data, 11 analysts cover the stock, with eight assigning a 'buy' rating, two a 'hold,' and one a 'sell.' The 12-month consensus target is Rs 1,523, offering an expected downside of 1.5%.
KFin Technologies
According to Gandhi, the stock is a 'buy', with a target price of Rs 1,465 and a stop loss at Rs 1,244. It has gained 172.16% in the last 12 months and 175.12% year-to-date. The stock’s relative strength index stands at 75.76.
Bloomberg shows that 13 analysts cover the stock: eight rate it 'buy,' three suggest 'hold,' and two recommend 'sell.' The consensus 12-month target price of Rs 1,083.38 implies a potential downside of 18.5%.
Multi Commodity Exchange Of India
Gandhi recommends purchasing the stock at Rs 6,698 with a target of Rs 7,418 and a stop loss at Rs 6,372. Over the past year, the stock has gained 109.75%, and in the year-to-date period, it has advanced 110.76%. Its relative strength index is currently at 58.61.
Bloomberg shows that 12 analysts cover the stock: four rate it 'buy,' six suggest 'hold,' and two recommend 'sell.' The consensus 12-month target price of Rs 6,629.10 implies a potential downside of 1%.
Gravita India
Goel advises buying the stock at Rs 2,407, targeting Rs 2,618 with a stop loss at Rs 2,196. The stock has shown a 120.81% change in the past 12 months and 124.24% year-to-date. The relative strength index is recorded at 64.89.
Bloomberg data indicates six analysts cover the stock, with all giving it a 'buy'. Analysts' consensus for the next 12 months sets the target at Rs 3,006.67, suggesting an upside of 24.9%.
Healthcare Global Enterprises
According to Goel, the stock is a 'buy' at Rs 541, with a target price of Rs 582 and a stop loss at Rs 499. It has gained 47.94% in the last 12 months and 46.34% year-to-date. The stock's relative strength index stands at 77.21.
Bloomberg data indicates nine analysts cover the stock, with eight giving it a 'buy' and one maintaining a 'hold'. The consensus 12-month target price of Rs 548 implies a potential upside of 1.3%.